Search Results 881-890 of 17070 for Semaglutide
The OLE period is intended to allow each patient at least 1 year of treatment with open-label benralizumab 30 mg administered SC every 4th week (earlier ...
The purpose of this study is to evaluate the safety and effectiveness of using Exablate Model 4000 Type-2.0/2.1 in adults with Glioblastoma brain tumors to ...
ExAblate delivers a pulse of focused ultrasound energy, or sonication, to the targeted tissue. In this particular study, the targeted tissue is uterine fibroids ...
Eculizumab injection is used to treat a type of blood disease called paroxysmal nocturnal hemoglobinuria (PNH). This medicine helps reduce red blood cell ...
The DRCFI treatment will influence the time to first pulmonary exacerbation compared to placebo. Participation eligibility. Participant eligibility includes age ...
The effectiveness and safety of TheraSphere will be evaluated in patients with colorectal cancer with metastases in the liver, who are scheduled to receive ...
To understand how helpful cannabinoids are in the management of different symptoms. To understand attitudes and beliefs about cannabis among patients on chronic ...
The purpose of this study is to determine the usefulness of palliative care consultations by a specialty physician and a pulmonologist for patients who have ...
The purpose of this study is to compare the percentage of time sedation depth is maintained within the target range, in absence of rescue sedation, as assessed ...
This clinical research study is designed to determine safety and effectiveness of the Surpass Flow Diverter (Surpass System), an investigational device ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!